Novo Nordisk (NVO) introduced a brand new $2.2 billion take care of San Francisco-based biotech Septerna (SEPN) for weight problems drugs — the newest in a sequence of strikes by
Novo Nordisk (NVO) introduced a brand new $2.2 billion take care of San Francisco-based biotech Septerna (SEPN) for weight problems drugs — the newest in a sequence of strikes by
US inventory futures fell on Wednesday after Nvidia (NVDA) revealed pricey new curbs on chip exports to China, and traders grappled with uncertainty over President Trump’s commerce coverage. Futures hooked